🎯 Other
What will Johnson & Johnson say during their next earnings call?

What will Johnson & Johnson say during their next earnings call? — Nipocalimab / Lupus

Live
Resolves Mar 31, 2027Kalshi
Volume-weighted avg
39%
No
61%
No (61%)Yes (39%)
Probability History
Loading...
Market snapshot
Status
Open
Category
Other
Vol 24h
$138
Liquidity
$225

Market intelligence

Kalshi currently prices this at 39%. Kalshi has moved down 7pp over the past 7 days.

About this market

If Nipocalimab / Lupus is said by any Johnson & Johnson representative (including the operator of the call) during the next Johnson & Johnson earnings call (including the Q+A), then the market resolves to Yes.

All outcomes · What will Johnson & Johnson say during their next earnings call?

Trade this marketLive prices
Avg probability
39%
probability of YES
Kalshi
TGWA
Resolution
Mar 31, 2027
Market is open
Market stats
24h volume$138
Liquidity$225
CategoryOther
StatusOpen